Clinical Trials Directory

Trials / Completed

CompletedNCT01940445

Impact of Synergistic Sequential Treatment (SST)

Impact of Synergistic Sequential Treatment (SST) of Fractional Non-ablative and Q-Switched Lasers on Skin Texture

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Lumenis Be Ltd. · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

At least thirty (30) subjects, Fitzpatrick-Goldman Skin Type II-V will be enrolled in 2 clinical sites; each clinic will enroll at least 15 subjects. Subjects should present visible wrinkles and/or elastosis requiring treatment. Hypothesis: The SST will improve the appearance of the wrinkles/elastosis as well as general skin tone by at least 25% as compared to M22 ResurFX 1565nm module alone, for at least 75% of the subjects.

Conditions

Interventions

TypeNameDescription
DEVICEM22 ResurFXFractional NA treatment (ResurFX) on one side of the face
DEVICEM22 ResurFX and QSFractional NA treatment followed by QS laser treatment (SST) on one side of the face

Timeline

Start date
2013-09-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-09-12
Last updated
2017-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01940445. Inclusion in this directory is not an endorsement.

Impact of Synergistic Sequential Treatment (SST) (NCT01940445) · Clinical Trials Directory